 Connection
Sandra Luna-Fineman to Survival Rate
This is a "connection" page, showing publications Sandra Luna-Fineman has written about Survival Rate.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.380 |
|
|
|
-
Pribnow AK, Ortiz R, Báez LF, Mendieta L, Luna-Fineman S. Effects of malnutrition on treatment-related morbidity and survival of children with cancer in Nicaragua. Pediatr Blood Cancer. 2017 Nov; 64(11).
Score: 0.089
-
Alvarez E, Seppa M, Rivas S, Fuentes L, Valverde P, Antillón-Klussmann F, Castellanos M, Sweet-Cordero EA, Messacar K, Kurap J, Bustamante M, Howard SC, Efron B, Luna-Fineman S. Improvement in treatment abandonment in pediatric patients with cancer in Guatemala. Pediatr Blood Cancer. 2017 Oct; 64(10).
Score: 0.089
-
Luna-Fineman S, Barnoya M, Bonilla M, Fu L, Baez F, Rodríguez-Galindo C. Retinoblastoma in Central America: report from the Central American Association of Pediatric Hematology Oncology (AHOPCA). Pediatr Blood Cancer. 2012 Apr; 58(4):545-50.
Score: 0.061
-
Velasquez-Herrera T, Valverde P, Fuentes S, Peña A, Ortiz R, Calderon P, Montero M, Gattuso G, Blanco J, Arreola M, Fernandez-Pineda I, Metzger M, Luna-Fineman S, Wilimas J, Spreafico F. Second Generation of AHOPCA (Asociación de Hemato-Oncología Pediátrica de Centro América) Treatment Guidelines for Wilms Tumor: A Report of Outcomes. Pediatr Blood Cancer. 2026 Feb; 73(2):e32148.
Score: 0.040
-
Valverde P, Velasquez T, Ortiz R, Fuentes-Alabi SL, Peña A, Gonzalez JF, Gutierrez TL, Melendez LE, Tome E, Arreola M, Valsecchi MG, Colombo V, Luna-Fineman S, Blanco-Lopez J, Metzger ML, Spreafico F. Challenges and Opportunities of a Multi-Institutional Treatment Guideline for Wilms Tumor in Low-Middle-Income Countries-A Report From the Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA). Pediatr Blood Cancer. 2025 May; 72(5):e31616.
Score: 0.038
-
Luna-Fineman S, Shannon KM, Atwater SK, Davis J, Masterson M, Ortega J, Sanders J, Steinherz P, Weinberg V, Lange BJ. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood. 1999 Jan 15; 93(2):459-66.
Score: 0.025
-
Wilimas JA, Wilson MW, Haik BG, Barnoya M, Fu L, Castellanos M, Bonilla M, Phillips B, Helveston EM, Luna-Fineman S, Ribeiro R, Rodriguez-Galindo C. Development of retinoblastoma programs in Central America. Pediatr Blood Cancer. 2009 Jul; 53(1):42-6.
Score: 0.013
-
Antillon F, Castellanos M, Valverde P, Luna-Fineman S, Garrido C, Serrato T, Rodriguez-Galindo C, Casanova M, Ferrari A. Treating Pediatric soft tissue sarcomas in a country with limited resources: the experience of the Unidad Nacional de Oncologia Pediatrica in Guatemala. Pediatr Blood Cancer. 2008 Dec; 51(6):760-4.
Score: 0.012
-
Lange BJ, Smith FO, Feusner J, Barnard DR, Dinndorf P, Feig S, Heerema NA, Arndt C, Arceci RJ, Seibel N, Weiman M, Dusenbery K, Shannon K, Luna-Fineman S, Gerbing RB, Alonzo TA. Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group. Blood. 2008 Feb 01; 111(3):1044-53.
Score: 0.012
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|